St. Josef Krankenhaus GmbH
- Address
- Auhofstrasse 189, Hietzing, 1130 Vienna, Austria
St. Josef Krankenhaus GmbH - Oncology Research Center
St. Josef Krankenhaus GmbH is a clinical research facility specializing in advanced oncology trials, with particular emphasis on breast and gastrointestinal malignancies. The center demonstrates extensive expertise in evaluating novel therapeutic combinations and targeted treatment strategies for patients with various stages of cancer, from early-stage disease to metastatic presentations.
- Hormone receptor-positive and HER2-negative breast cancer adjuvant therapies, including CDK4/6 inhibitor combinations
- BRCA-mutated breast cancer treatment with PARP inhibitors in the adjuvant setting
- HER2-positive gastric and gastroesophageal junction cancers utilizing antibody-drug conjugates and immunotherapy combinations
The research center actively participates in international phase III randomized trials investigating cutting-edge treatment modalities. Their clinical portfolio reflects a commitment to precision medicine approaches, including genetic biomarker-driven therapies and novel combinations with endocrine therapy, chemotherapy, and immunotherapy agents. The center's involvement in pivotal adjuvant and first-line metastatic trials positions it at the forefront of developing evidence-based standards of care for cancer patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Daiichi Sankyo Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 152 other sites in Austria
Therapeutic Area Benchmark — Austria
Select a therapeutic area to compare against other sites in Austria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Austria
Market Share
Country: Austria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in St. Josef Krankenhaus GmbH
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Olaparib as Adjuvant Therapy in Germline BRCA1/2 Mutated High-Risk HER2-Negative Primary Breast Cancer: A Phase III Randomized Study | AstraZeneca AB | Phase III | Not Recruiting | Aug 2014 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capecitabine | 1 | Unknown | 2025-06-10 | 2025-06-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.